JFS Wealth Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

JFS Wealth Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-800	Closed	-$4K	–	495
2016 Q3	$4K	Hold	800	–	–	﹤0.01%	434
2016 Q2	$5K	Hold	800	–	–	﹤0.01%	436
2016 Q1	$5K	Hold	800	–	–	﹤0.01%	455
2015 Q4	$5K	Hold	800	–	–	﹤0.01%	456
2015 Q3	$5K	Hold	800	–	–	﹤0.01%	393
2015 Q2	$5K	Hold	800	–	–	﹤0.01%	412
2015 Q1	$5K	Hold	800	–	–	﹤0.01%	418
2014 Q4	$6K	Hold	800	–	–	﹤0.01%	428
2014 Q3	$7K	Hold	800	–	–	﹤0.01%	367
2014 Q2	$7K	Buy	+800	New	+$6.07K	﹤0.01%	358

Other funds holding SPPI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JFS Wealth Advisors's SPPI Position: Q4 2016 in Review

JFS Wealth Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2016, closing a stake of 800 shares — an estimated $4K sold.

JFS Wealth Advisors first reported a position in SPPI in Q2 2014 and held it in 10 quarters. The position peaked at $7K in Q3 2014. 139 funds tracked by Wall St. Rank hold SPPI as of Q4 2016.

JFS Wealth Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
JFS Wealth Advisors sold 800 Spectrum Pharmaceuticals Inc shares in Q4 2016, an estimated $4K.
JFS Wealth Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2014 and held it in 10 quarters.
JFS Wealth Advisors's Spectrum Pharmaceuticals Inc position peaked at $7K in Q3 2014.
139 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2016.

Based on JFS Wealth Advisors's 13F filing for Q4 2016, filed 30 Jan 2017.